Association between the Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Lymphoma

      Introduction: Lymphoma is a common hematopoietic cancer. Immunosuppression is one of the main risk factors for the development of lymphoma. The interleukin (IL)-1 receptor antagonist IL1RN, which binds to the IL-1 receptor, moderates a variety of immune responses related to IL-1. We...

Full description

Bibliographic Details
Main Authors: Hosna Sarani, Behrouz Molashahi, Mohsen Taheri, Gholamreza Bahari, Seyed Mahdi Hashemi, Mohammad Hashemi, Saeid Ghavami
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2021-04-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1326